|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/18 | |
| C07K 16/30 | |||
| A61P 35/02 | |||
| C07K 14/725 | |||
| C07K 14/47 | |||
| A61K 39/00 |
| (11) | Patento numeris | 3092252 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15701442.4 |
| Europos patento paraiškos padavimo data | 2015-01-08 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-11-16 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-09-18 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/010620 |
| Data | 2015-01-08 |
| (87) | Numeris | WO 2015/105973 |
| Data | 2015-07-16 |
| (30) | Numeris | Data | Šalis |
| 201461924967 P | 2014-01-08 | US |
| (72) |
WIESTNER, Adrian U., US
SKARZYNSKI, Martin W., US
LINDORFER, Margaret A., US
TAYLOR, Ronald P., US
RADER, Christoph, US
VIRE, Bérengčre, FR
|
| (73) |
The U.S.A. as represented by the Secretary, Department of Health and Human Services,
Office of Technology Transfer National Institutes of Health 6011 Executive Boulevard, Suite 325 MSC 7660, Bethesda, MD 20892-7660,
US
University of Virginia Patent Foundation d/b/a University of Virginia Licensing & Ventures Group, 250 West Main Street, Suite 300, Charlottesville, VA 22902, US |
| (54) | ANTIBODY TARGETING CELL SURFACE DEPOSITED COMPLEMENT PROTEIN C3D AND USE THEREOF |
| ANTIBODY TARGETING CELL SURFACE DEPOSITED COMPLEMENT PROTEIN C3D AND USE THEREOF |